As of Feb 4, 2025, the Zimmer Biomet Holdings stock's PE ratio is 20.46. This results from the current EPS of $5.27 and stock price of $107.8. The PE ratio has decreased by 15% from the past four quarters average of 24.1.
The PE ratio of Zimmer Biomet Holdings has averaged 79.32 over the last ten years. The current P/E ratio of 20.46 is 74% lower than the historical average. In the past ten years, ZBH's PE ratio peaked in the Jun 2020 quarter at 596.8, when the stock price was $119.36 and the EPS was $0.2. The lowest point was in the Mar 2018 quarter, when it reached 13.06 with a price of $109.04 and an EPS of $8.35.
Maximum annual increase: 394.1% in 2015
Maximum annual decrease: -80.07% in 2017
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2023 | 24.79 | -78.61% | $121.7 | $4.91 |
2022 | 115.91 | 76.1% | $127.5 | $1.1 |
2021 | 65.82 | N/A | $127.04 | $1.93 |
2020 | N/A | N/A | $154.09 | -$0.67 |
2019 | 27.12 | N/A | $149.68 | $5.52 |
2018 | N/A | N/A | $103.72 | -$1.86 |
2017 | 13.44 | -80.07% | $120.67 | $8.98 |
2016 | 67.45 | -48.72% | $103.2 | $1.53 |
2015 | 131.53 | 394.1% | $102.59 | $0.78 |
2014 | 26.62 | 31.39% | $113.42 | $4.26 |
2013 | 20.26 | 31.3% | $93.19 | $4.6 |
2012 | 15.43 | 16.98% | $66.66 | $4.32 |
2011 | 13.19 | -26.76% | $53.42 | $4.05 |
2010 | 18.01 | 1.75% | $53.68 | $2.98 |
2009 | 17.7 | 63.28% | $59.11 | $3.34 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Sep 2024 | 20.48 | -9.06% | $107.95 | $5.27 |
Jun 2024 | 22.52 | -20.82% | $108.53 | $4.82 |
Mar 2024 | 28.44 | 14.72% | $131.98 | $4.64 |
Dec 2023 | 24.79 | -50.07% | $121.7 | $4.91 |
Sep 2023 | 49.65 | -18.16% | $112.22 | $2.26 |
Jun 2023 | 60.67 | 0.02% | $145.6 | $2.4 |
Mar 2023 | 60.66 | -47.67% | $129.2 | $2.13 |
Dec 2022 | 115.91 | 46.35% | $127.5 | $1.1 |
Sep 2022 | 79.2 | -17.08% | $104.55 | $1.32 |
Jun 2022 | 95.51 | -21.59% | $105.06 | $1.1 |
Mar 2022 | 121.81 | 85.07% | $127.9 | $1.05 |
Dec 2021 | 65.82 | 77.65% | $127.04 | $1.93 |
Sep 2021 | 37.05 | 1.84% | $146.36 | $3.95 |
Jun 2021 | 36.38 | -37.73% | $160.82 | $4.42 |
Mar 2021 | 58.42 | N/A | $160.08 | $2.74 |
Currently, ZBH's PE ratio is lower than the 3, 5 and 10-year averages.
ZBH's PE ratio stands lower than its peer stocks BSX and SYK, but it is higher than EW's. Zimmer Biomet Holdings is presently trading at a lower PE ratio (20.46) than its peer group average of 46.29.
Stock name | PE ratio | Market cap |
---|---|---|
EW Edwards Lifesciences Corp | 10.28 | $42.07B |
ZBH Zimmer Biomet Holdings Inc | 20.46 | $21.46B |
SYK Stryker Corp | 41.61 | $149.59B |
COO Cooper Companies Inc | 48.38 | $19.02B |
BSX Boston Scientific Corp | 84.87 | $152.6B |
ZBH stock has a price to earnings ratio of 20.46 as of Feb 4, 2025.
The average PE ratio for ZBH stock over the past 3 years is 61.79.
The average PE ratio for ZBH stock over the past 5 years is 89.93.
Over the last ten years, the quarterly PE ratio reached a historic high of 596.8 in the Jun 2020 quarter.
ZBH's price to earnings ratio is currently 74% below its 10-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Feb 4, 2025), Zimmer Biomet Holdings's stock price is $107.8. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $5.27. Therefore, Zimmer Biomet Holdings's PE ratio for today is 20.46. PE RATIO(20.46) = STOCK PRICE($107.8) / TTM EPS($5.27)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.